Antiplatelet therapy in ACS: Choices and Controversies
ESC 2022 Highlights
The latest in Acute Coronary Syndrome from ESC 2022
From the 2022 European Society of Cardiology (ESC) congress in Barcelona, receive original content on developments in acute coronary syndrome (ACS) treatments, focusing on international guideline updates, and antiplatelet therapies such as P2Y12 inhibitors.